Home > National Drug Code (NDC) > Lithium Carbonate

Lithium Carbonate - 0615-5593-31 - (Lithium Carbonate)

Alphabetical Index


Drug Information of Lithium Carbonate

Product NDC: 0615-5593
Proprietary Name: Lithium Carbonate
Non Proprietary Name: Lithium Carbonate
Active Ingredient(s): 300    mg/1 & nbsp;   Lithium Carbonate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED, EXTENDED RELEASE
Coding System: National Drug Codes(NDC)

Labeler Information of Lithium Carbonate

Product NDC: 0615-5593
Labeler Name: NCS HealthCare of KY, Inc dba Vangard Labs
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076832
Marketing Category: ANDA
Start Marketing Date: 20041028

Package Information of Lithium Carbonate

Package NDC: 0615-5593-31
Package Description: 31 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-5593-31)

NDC Information of Lithium Carbonate

NDC Code 0615-5593-31
Proprietary Name Lithium Carbonate
Package Description 31 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-5593-31)
Product NDC 0615-5593
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Lithium Carbonate
Dosage Form Name TABLET, FILM COATED, EXTENDED RELEASE
Route Name ORAL
Start Marketing Date 20041028
Marketing Category Name ANDA
Labeler Name NCS HealthCare of KY, Inc dba Vangard Labs
Substance Name LITHIUM CARBONATE
Strength Number 300
Strength Unit mg/1
Pharmaceutical Classes Mood Stabilizer [EPC]

Complete Information of Lithium Carbonate


General Information